ARCHIVES

Iressa Authorization In Europe Clarifies Differences Between U.S., E.U. Standards

This article is from The Cancer Letter archive.

Vol. 35 No. 30 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

King Named Lombardi Center Deputy Director; SWOG Needs New Exec; Murphy Leaves St. Jude

July 22, 1988

Groups Urge FDA To Take Action Against Tobacco Products

June 27, 2014

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007

DCT Board Restores Funding to Rosenberg’s Lymphocyte Projects

June 17, 1994

NCI Plans Program To Help Academics With Initial Stages of Drug Discovery.

November 30, 2007

NCI-Approved Clinical Trials

September 28, 2001